High throughput in vivo functional validation of candidate congenital heart disease genes in Drosophila

eLife

Volumn 6, Issue , 2017, Pages

  Zhu, Jun Yi ^a   Fu, Yulong ^a   Nettleton, Margaret ^a   Richman, Adam ^a   Han, Zhe ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; CHD GENE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DROSOPHILA; GENE; GENE SEQUENCE; GENE SILENCING; HIGH THROUGHPUT SCREENING; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; DISEASE MODEL; GENETIC SCREENING; GENETICS; HEART DISEASE; HUMAN; RNA INTERFERENCE;

DROSOPHILA PROTEIN;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; DROSOPHILA PROTEINS; GENE SILENCING; GENETIC TESTING; HEART DISEASES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; RNA INTERFERENCE;

EID: 85013466628     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.22617     Document Type: Article

References (35)

1. Ashley EA. 2015. The precision medicine initiative: a new national effort. JAMA 313:2119-2120. doi:10.1001/jama.2015.3595,PMID:25928209
2. Bier E, Bodmer R. 2004. Drosophila, an emerging model for cardiac disease. Gene 342:1-11. doi:10.1016/j.gene.2004.07.018,PMID:15527959
3. Bier E. 2005. Drosophila, the golden bug, emerges as a tool for human genetics. Nature Reviews Genetics 6:9-23. doi:10.1038/nrg1503,PMID:15630418
4. Brand AH, Perrimon N. 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415. PMID: 8223268
5. Cagan RL. 2011. The Drosophila nephrocyte. Current Opinion in Nephrology and Hypertension 20:409-415. doi:10.1097/MNH.0b013e328347ae02,PMID:21610496
6. Carroll KJ, Makarewich CA, McAnally J, Anderson DM, Zentilin L, Liu N, Giacca M, Bassel-Duby R, Olson EN. 2016. A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9. PNAS 113:338-343. doi:10.1073/pnas.1523918113,PMID:26719419
7. Chien S, Reiter LT, Bier E, Gribskov M. 2002. Homophila: human disease gene cognates in Drosophila. Nucleic Acids Research 30:149-151. doi:10.1093/nar/30.1.149,PMID:11752278
8. Delgado-Olguín P, Huang Y, Li X, Christodoulou D, Seidman CE, Seidman JG, Tarakhovsky A, Bruneau BG. 2012. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nature Genetics 44:343-347. doi:10.1038/ng.1068,PMID:22267199
9. Diop SB, Bodmer R. 2015. Gaining insights into diabetic cardiomyopathy from Drosophila. Trends in Endocrinology & Metabolism 26:618-627. doi:10.1016/j.tem.2015.09.009,PMID:26482877
10. Drechsler M, Schmidt AC, Meyer H, Paululat A. 2013. The conserved ADAMTS-like protein lonely heart mediates matrix formation and cardiac tissue integrity. PLoS Genetics 9:e1003616. doi:10.1371/journal.pgen.1003616,PMID:23874219
11. Gelb B, Brueckner M, Chung W, Goldmuntz E, Kaltman J, Kaski JP, Kim R, Kline J, Mercer-Rosa L, Porter G, Roberts A, Rosenberg E, Seiden H, Seidman C, Sleeper L, Tennstedt S, Kaltman J, Schramm C, Burns K, Pearson G, et al. 2013. The congenital heart disease genetic network study: rationale, design, and early results. Circulation Research 112:698-706. doi:10.1161/CIRCRESAHA.111.300297,PMID:23410879
12. Han Z, Olson EN. 2005. Hand is a direct target of Tinman and GATA factors during Drosophila cardiogenesis and hematopoiesis. Development 132:3525-3536. doi:10.1242/dev.01899,PMID:15975941
13. Han Z, Yi P, Li X, Olson EN. 2006. Hand, an evolutionarily conserved bHLH transcription factor required for Drosophila cardiogenesis and hematopoiesis. Development 133:1175-1182. doi:10.1242/dev.02285,PMID:16467358
14. He A, Ma Q, Cao J, von Gise A, Zhou P, Xie H, Zhang B, Hsing M, Christodoulou DC, Cahan P, Daley GQ, Kong SW, Orkin SH, Seidman CE, Seidman JG, Pu WT. 2012. Polycomb repressive complex 2 regulates normal development of the mouse heart. Circulation Research 110:406-415. doi:10.1161/CIRCRESAHA.111.252205,PMID:22158708
15. Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. Journal of the American College of Cardiology 39:1890-1900. doi:10.1016/S0735-1097(02)01886-7,PMID:12084585
16. Hoffman JI. 1990. Congenital heart disease: incidence and inheritance. Pediatric Clinics of North America 37:25-43. doi:10.1016/S0031-3955(16)36830-4,PMID:2408002
17. Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, Perrimon N, Mohr SE. 2011. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics 12:357. doi:10.1186/1471-2105-12-357,PMID:21880147
18. Kaneda R, Takada S, Yamashita Y, Choi YL, Nonaka-Sarukawa M, Soda M, Misawa Y, Isomura T, Shimada K, Mano H. 2009. Genome-wide histone methylation profile for heart failure. Genes to Cells 14:69-77. doi:10.1111/j.1365-2443.2008.01252.x,PMID:19077033
19. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. doi:10.1006/meth.2001.1262,PMID:11846609
20. Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN. 2016. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351:400-403. doi:10.1126/science.aad5725,PMID:26721683
21. Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R, Olson EN. 2014. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science 345:1184-1188. doi:10.1126/science.1254445,PMID:25123483
22. Na J, Sweetwyne MT, Park AS, Susztak K, Cagan RL. 2015. Diet-Induced podocyte dysfunction in Drosophila and mammals. Cell Reports 12:636-647. doi:10.1016/j.celrep.2015.06.056,PMID:26190114
23. Neely GG, Kuba K, Cammarato A, Isobe K, Amann S, Zhang L, Murata M, Elmén L, Gupta V, Arora S, Sarangi R, Dan D, Fujisawa S, Usami T, Xia CP, Keene AC, Alayari NN, Yamakawa H, Elling U, Berger C, et al. 2010. A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell 141: 142-153. doi:10.1016/j.cell.2010.02.023,PMID:20371351
24. Ni JQ, Markstein M, Binari R, Pfeiffer B, Liu LP, Villalta C, Booker M, Perkins L, Perrimon N. 2008. Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster. Nature Methods 5:49-51. doi:10.1038/nmeth1146,PMID:18084299
25. Ni JQ, Zhou R, Czech B, Liu LP, Holderbaum L, Yang-Zhou D, Shim HS, Tao R, Handler D, Karpowicz P, Binari R, Booker M, Brennecke J, Perkins LA, Hannon GJ, Perrimon N. 2011. A genome-scale shRNA resource for transgenic RNAi in Drosophila. Nature Methods 8:405-407. doi:10.1038/nmeth.1592,PMID:21460824
26. Olson EN. 2006. Gene regulatory networks in the evolution and development of the heart. Science 313:1922-1927. doi:10.1126/science.1132292,PMID:17008524
27. Owusu-Ansah E, Perrimon N. 2014. Modeling metabolic homeostasis and nutrient sensing in Drosophila: implications for aging and metabolic diseases. Disease Models & Mechanisms 7:343-350. doi:10.1242/dmm.012989,PMID:24609035
28. Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. 2001. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Research 11:1114-1125. doi:10.1101/gr.169101,PMID:11381037
29. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. 2008. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. The Journal of Pediatrics 153:807-813. doi:10.1016/j.jpeds.2008.05.059,PMID:18657826
30. Vogler G, Bodmer R. 2015. Cellular mechanisms of Drosophila heart morphogenesis. Journal of Cardiovascular Development and Disease 2:2-16. doi:10.3390/jcdd2010002,PMID:26236710
31. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding H, Wylie JN, Pico AR, Capra JA, Erwin G, Kattman SJ, Keller GM, Srivastava D, Levine SS, Pollard KS, Holloway AK, Boyer LA, Bruneau BG. 2012. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151:206-220. doi:10.1016/j.cell.2012.07.035,PMID:22981692
32. Yi P, Han Z, Li X, Olson EN. 2006. The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Ggamma1. Science 313:1301-1303. doi:10.1126/science.1127704,PMID:16857902
33. Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, Romano-Adesman A, Bjornson RD, Breitbart RE, Brown KK, Carriero NJ, Cheung YH, Deanfield J, DePalma S, Fakhro KA, Glessner J, Hakonarson H, Italia MJ, Kaltman JR, Kaski J, et al. 2013. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498: 220-223. doi:10.1038/nature12141,PMID:23665959
34. Zhang F, Zhao Y, Chao Y, Muir K, Han Z. 2013. Cubilin and amnionless mediate protein reabsorption in Drosophila nephrocytes. Journal of the American Society of Nephrology 24:209-216. doi:10.1681/ASN.2012080795,PMID:23264686
35. Zhang QJ, Liu ZP. 2015. Histone methylations in heart development, congenital and adult heart diseases. Epigenomics 7:321-330. doi:10.2217/epi.14.60,PMID:25942538